转移性结直肠癌患者体力活动与生存及进展的关联:CALGB/SWOG 80405研究结果
该研究为嵌套于III期临床试验的前瞻性队列研究,纳入1218例转移性结直肠癌患者,评估体力活动与总生存、无进展生存及治疗相关不良事件的关系。结果显示体力活动与总生存关联未达统计学显著,但较高体力活动与较长无进展生存及较低严重不良事件风险相关。
要点
- 每周≥18 MET小时体力活动与无进展生存改善相关(aHR 0.83)。
- 每周≥9 MET小时体力活动与严重治疗相关不良事件风险降低相关(aHR 0.73)。
核心结论
- 在转移性结直肠癌患者中,体力活动与总生存的关联未达统计学显著。
- 较高体力活动与较长无进展生存和较低首次≥3级治疗相关不良事件风险相关。
研究设计与样本
- 前瞻性队列研究,嵌套于CALGB/SWOG 80405 III期临床试验(NCT00265850)。
- 最终队列纳入1218例转移性结直肠癌患者,治疗开始后1个月内填写验证过的体力活动问卷。
- 排除体力活动评估后60天内进展或死亡的患者,采用Cox比例风险回归调整已知预后因素、合并症和体重减轻。
临床怎么用
- 对转移性结直肠癌患者,可评估其体力活动水平作为预后及治疗耐受性的参考信息。
- 鼓励患者保持适度体力活动可能有助于改善无进展生存并降低严重治疗相关不良事件风险。
局限性
- 体力活动通过问卷自报,可能存在测量误差和回忆偏倚。
- 研究为观察性设计,不能确立体力活动与结局的因果关系。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Regular physical activity is associated with reduced risk of recurrence and mortality in patients with nonmetastatic colorectal cancer. Its influence on patients with advanced/metastatic colorectal cancer (mCRC) has been largely unexplored. PATIENTS AND METHODS: We conducted a prospective cohort study nested in Cancer and Leukemia Group B (Alliance)/SWOG 80405 (ClinicalTrials.gov identifier: NCT00265850), a National Cancer Institute-sponsored phase III trial of systemic therapy for mCRC. Within 1 month after therapy initiation, patients were invited to complete a validated questionnaire that reported average physical activity over the previous 2 months. On the basis of responses, we calculated metabolic equivalent task (MET) hours per week to quantify physical activity. The primary end point of the clinical trial and this companion study was overall survival (OS). Secondary end points included progression-free survival (PFS) and first grade 3 or greater treatment-related adverse events. To minimize confounding by poor and declining health, we excluded patients who experienced progression or died within 60 days of activity assessment and used Cox proportional hazards regression analysis to adjust for known prognostic factors, comorbidities, and weight loss. RESULTS: The final cohort included 1,218 patients. Compared with patients engaged in less than 3 MET hours per week of physical activity, patients engaged in 18 or more MET hours per week experienced an adjusted hazard ratio for OS of 0.85 (95% CI, 0.71 to 1.02; PTrend = .06) and for PFS of 0.83 (95% CI, 0.70 to 0.99; PTrend = .01). Compared with patients engaging in less than 9 MET hours per week, patients engaging in 9 or more MET hours per week experienced an adjusted hazard ratio for grade 3 or greater treatment-related adverse events of 0.73 (95% CI, 0.62 to 0.86; PTrend < .001). CONCLUSION: Among patients with mCRC in Cancer and Leukemia Group B (Alliance)/SWOG 80405, association of physical activity with OS was not statistically significant. Greater physical activity was associated with longer PFS and lower adjusted risk for first grade 3 or greater treatment-related adverse events.
引用
- Guercio BJ, Zhang S, Ou FS, et al. Associations of Physical Activity With Survival and Progression in Metastatic Colorectal Cancer: Results From Cancer and Leukemia Group B (Alliance)/SWOG 80405. J Clin Oncol. 2019. PMID: 31408415. doi:10.1200/JCO.19.01019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。